EVANS KOMEN: Open Payments
NPI 1003216839 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 105 payments from 14 companies in 2025. Trend: 2023 $1,337 · 2024 $1,535 · 2025 $1,719
Food & beverage: $1,607Education: $112
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $319 |
| ABBVIE INC. | 20 | $299 |
| Otsuka America Pharmaceutical, Inc. | 12 | $232 |
| Teva Pharmaceuticals USA, Inc. | 6 | $202 |
| Neurocrine BioSciences, Inc. | 19 | $164 |
| Supernus Pharmaceuticals, Inc. | 13 | $153 |
| Alkermes, Inc. | 5 | $97 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| HARMONY BIOSCIENCES LLC | 2 | $40 |
Products named: CAPLYTA, VRAYLAR, REXULTI, INGREZZA, Qelbree, ARISTADA, AUSTEDO XR, Jornay PM.
Industry payments across IA — which companies pay providers there.
